{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:44:08Z","timestamp":1794411848809,"version":"4.9.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rapid eye movement sleep behavior disorder (RBD) is the most specific prodromal marker of Parkinson\u2019s disease (PD), affecting 40\u201350% of PD patients. PD with RBD (RBD-PD) represents a clinically aggressive subtype characterized by more severe motor and nonmotor symptoms, prominent autonomic dysfunction, and accelerated disease progression; however, its underlying pathogenesis remains poorly understood. Here, we integrated multiplatform metabolomics and proteomics with precise clinical phenotyping to delineate molecular signatures in plasma across different PD subtypes. Our analyses demonstrated that PD patients exhibit significant metabolic reprogramming, characterized by a shift in energy metabolism from the tricarboxylic acid cycle toward glycolysis, a dysregulated urea cycle, and lipid remodeling, as well as extensive activation of inflammatory and immune responses involving the PI3K-Akt, IL-17, NF-kappaB, MAPK and TNF signaling pathways. Notably, the RBD-PD subgroup exhibited distinctive metabolic disturbances characterized by the accumulation of gut microbiota-derived toxic aromatic amino acid catabolites. Importantly, these alterations were also observed in idiopathic RBD (iRBD) patients, representing the prodromal stage of PD. By integrating metagenomic profiles, we further revealed that gut microbial dysbiosis in RBD-PD and iRBD drives a functional shift away from dietary fiber fermentation and toward enhanced degradation of protein, aromatic amino acids, glycine, and intestinal mucin glycans. This metabolic reprogramming is associated with exacerbated oxidative stress, neuroinflammation, and accelerated pathological progression. These findings provide multiomic evidence that clarifies the molecular heterogeneity in PD and highlights gut microbiota-driven dysfunction as a key contributor to both the iRBD and RBD-PD subtypes.<\/jats:p>","DOI":"10.1038\/s41392-026-02613-8","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:52:01Z","timestamp":1774878721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Distinct metabolomic and proteomic signatures in Parkinson\u2019s disease patients with REM sleep behavior disorder"],"prefix":"10.1038","volume":"11","author":[{"given":"Yaping","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisa","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-6672","authenticated-orcid":false,"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8596-6108","authenticated-orcid":false,"given":"Huaibin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4298-3554","authenticated-orcid":false,"given":"Guowang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7459-2705","authenticated-orcid":false,"given":"Weidong","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38248-4","volume":"14","author":"B Huang","year":"2023","unstructured":"Huang, B. et al. Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives. Nat. Commun. 14, 2501 (2023).","journal-title":"Nat. Commun."},{"key":"2613_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner, C. M. & Ostrem, J. L. Parkinson\u2019s Disease. N. Engl. J. Med. 391, 442\u2013452 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2613_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen, X. et al. Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct. Target Ther. 8, 73 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","volume":"43","author":"A Galbiati","year":"2019","unstructured":"Galbiati, A. et al. The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. Sleep. Med Rev. 43, 37\u201346 (2019).","journal-title":"Sleep. Med Rev."},{"key":"2613_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/mds.29643","volume":"39","author":"G Ongari","year":"2023","unstructured":"Ongari, G. et al. Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson\u2019s Disease? Mov. Disord. 39, 294\u2013304 (2023).","journal-title":"Mov. Disord."},{"key":"2613_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41531-025-00874-8","volume":"11","author":"AE Martinez-Nunez","year":"2025","unstructured":"Martinez-Nunez, A. E. et al. Clinically probable RBD is an early predictor of malignant non-motor Parkinson\u2019s disease phenotypes. NPJ Parkinsons Dis. 11, 25 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1002\/mds.28763","volume":"36","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Longitudinal Changes in Parkinson\u2019s Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study. Mov. Disord. 36, 2821\u20132832 (2021).","journal-title":"Mov. Disord."},{"key":"2613_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41531-022-00373-0","volume":"8","author":"GM Riboldi","year":"2022","unstructured":"Riboldi, G. M. et al. Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson\u2019s disease phenotypes. NPJ Parkinsons Dis. 8, 110 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"2613_CR9","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/ene.12723","volume":"22","author":"KA Bj\u00f8rnar\u00e5","year":"2015","unstructured":"Bj\u00f8rnar\u00e5, K. A., Dietrichs, E. & Toft, M. Longitudinal assessment of probable rapid eye movement sleep behaviour disorder in Parkinson\u2019s disease. Eur. J. Neurol. 22, 1242\u20131244 (2015).","journal-title":"Eur. J. Neurol."},{"key":"2613_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41531-022-00303-0","volume":"8","author":"G Ye","year":"2022","unstructured":"Ye, G. et al. Evolution patterns of probable REM sleep behavior disorder predicts Parkinson\u2019s disease progression. NPJ Parkinsons Dis. 8, 36 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"2613_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41593-025-01910-9","volume":"28","author":"KB Andersen","year":"2025","unstructured":"Andersen, K. B. et al. Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals. Nat. Neurosci. 28, 925\u2013936 (2025).","journal-title":"Nat. Neurosci."},{"key":"2613_CR12","first-page":"S281","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer, P. & Van Den Berge, N. Brain-First versus Gut-First Parkinson\u2019s Disease: A Hypothesis. J. Parkinsons Dis. 9, S281\u2013s295 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"2613_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.14336\/AD.2023.0518","volume":"15","author":"P Zhang","year":"2024","unstructured":"Zhang, P. et al. Relationships Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson\u2019s Disease: Indication from Gut Microbiota Alterations. Aging Dis. 15, 357\u2013368 (2024).","journal-title":"Aging Dis."},{"key":"2613_CR14","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1212\/WNL.0000000000002126","volume":"85","author":"FS Sprenger","year":"2015","unstructured":"Sprenger, F. S. et al. Enteric nervous system \u03b1-synuclein immunoreactivity in idiopathic REM sleep behavior disorder. Neurology 85, 1761\u20131768 (2015).","journal-title":"Neurology"},{"key":"2613_CR15","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/mds.29803","volume":"39","author":"J Du","year":"2024","unstructured":"Du, J. et al. Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD) Shares Similar Fecal Short-Chain Fatty Acid Alterations with Multiple System Atrophy (MSA) and Parkinson\u2019s Disease (PD). Mov. Disord. 39, 1397\u20131402 (2024).","journal-title":"Mov. Disord."},{"key":"2613_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg, D. et al. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nat. Rev. Neurol. 17, 349\u2013361 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"2613_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00590-24","volume":"10","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Alterations of fecal microbiota and plasma metabolome in patients with Parkinson\u2019s disease with rapid eye movement sleep disorder. mSphere 10, e0059024 (2025).","journal-title":"mSphere"},{"key":"2613_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","volume":"16","author":"Y Shao","year":"2021","unstructured":"Shao, Y. et al. Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry. Mol. Neurodegener. 16, 4 (2021).","journal-title":"Mol. Neurodegener."},{"key":"2613_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70003","volume":"30","author":"H Yang","year":"2024","unstructured":"Yang, H. et al. Fecal microbiota from patients with Parkinson\u2019s disease intensifies inflammation and neurodegeneration in A53T mice. CNS Neurosci. Ther. 30, e70003 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"2613_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41531-025-01040-w","volume":"11","author":"S Lee","year":"2025","unstructured":"Lee, S. et al. Enrichment of gut-derived metabolites in a Parkinson\u2019s disease subtype with REM sleep behavior disorder. NPJ Parkinsons Dis. 11, 189 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"2613_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target Ther. 8, 267 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2613_CR22","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart, D. S. et al. HMDB 5.0: the Human Metabolome Database for 2022. Nucleic Acids Res. 50, D622\u2013d631 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2613_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57142-9","volume":"16","author":"G Gao","year":"2025","unstructured":"Gao, G., Shi, Y., Deng, H.-X. & Krainc, D. Dysregulation of mitochondrial \u03b1-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson\u2019s disease models. Nat. Commun. 16, 1982 (2025).","journal-title":"Nat. Commun."},{"key":"2613_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","volume":"88","author":"MJ Firbank","year":"2017","unstructured":"Firbank, M. J. et al. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. J. Neurol. Neurosurg. Psychiatry 88, 310\u2013316 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2613_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00429-010-0246-0","volume":"214","author":"P Borghammer","year":"2010","unstructured":"Borghammer, P. et al. Cortical hypometabolism and hypoperfusion in Parkinson\u2019s disease is extensive: probably even at early disease stages. Brain Struct. Funct. 214, 303\u2013317 (2010).","journal-title":"Brain Struct. Funct."},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/metabo15030208","volume":"15","author":"EA Ostrakhovitch","year":"2025","unstructured":"Ostrakhovitch, E. A., Ono, K. & Yamasaki, T. R. Metabolomics in Parkinson\u2019s Disease and Correlation with Disease State. Metabolites 15, 208 (2025).","journal-title":"Metabolites"},{"key":"2613_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40478-022-01424-6","volume":"10","author":"CE Toomey","year":"2022","unstructured":"Toomey, C. E. et al. Mitochondrial dysfunction is a key pathological driver of early stage Parkinson\u2019s. Acta Neuropathol. Commun. 10, 134 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"105605","DOI":"10.1016\/j.nbd.2021.105605","volume":"163","author":"J Li","year":"2022","unstructured":"Li, J. et al. Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson\u2019s disease. Neurobiol. Dis. 163, 105605 (2022).","journal-title":"Neurobiol. Dis."},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez, P. et al. Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599, 650\u2013656 (2021).","journal-title":"Nature"},{"key":"2613_CR30","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.molcel.2025.05.021","volume":"85","author":"SJ Ham","year":"2025","unstructured":"Ham, S. J. et al. Mitochondrial fumarate inhibits Parkin-mediated mitophagy. Mol. Cell. 85, 2287\u20132302.e9 (2025).","journal-title":"Mol. Cell."},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.cmet.2019.03.014","volume":"29","author":"DA Cappel","year":"2019","unstructured":"Cappel, D. A. et al. Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver. Cell Metab. 29, 1291\u20131305.e8 (2019).","journal-title":"Cell Metab."},{"key":"2613_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuint.2011.09.007","volume":"60","author":"KV Rama Rao","year":"2012","unstructured":"Rama Rao, K. V. & Norenberg, M. D. Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochem Int. 60, 697\u2013706 (2012).","journal-title":"Neurochem Int."},{"key":"2613_CR33","doi-asserted-by":"publisher","first-page":"120266","DOI":"10.1016\/j.watres.2023.120266","volume":"242","author":"J Li","year":"2023","unstructured":"Li, J. et al. Multidrug-resistant plasmid RP4 increases NO and N(2)O yields via the electron transport system in Nitrosomonas europaea ammonia oxidation. Water Res. 242, 120266 (2023).","journal-title":"Water Res."},{"key":"2613_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-025-01038-9","volume":"47","author":"E Karadima","year":"2025","unstructured":"Karadima, E., Chavakis, T. & Alexaki, V. I. Arginine metabolism in myeloid cells in health and disease. Semin Immunopathol. 47, 11 (2025).","journal-title":"Semin Immunopathol."},{"key":"2613_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12455","volume":"13","author":"N Vassileff","year":"2024","unstructured":"Vassileff, N. et al. Microglial activation induces nitric oxide signalling and alters protein S-nitrosylation patterns in extracellular vesicles. J. Extracell. Vesicles. 13, e12455 (2024).","journal-title":"J. Extracell. Vesicles."},{"key":"2613_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41531-022-00370-3","volume":"8","author":"MG Stykel","year":"2022","unstructured":"Stykel, M. G. & Ryan, S. D. Nitrosative stress in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 104 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"2613_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.toxlet.2016.11.002","volume":"265","author":"QS Zhang","year":"2017","unstructured":"Zhang, Q. S., Heng, Y., Yuan, Y. H. & Chen, N. H. Pathological \u03b1-synuclein exacerbates the progression of Parkinson\u2019s disease through microglial activation. Toxicol. Lett. 265, 30\u201337 (2017).","journal-title":"Toxicol. Lett."},{"key":"2613_CR38","doi-asserted-by":"publisher","first-page":"8941327","DOI":"10.1155\/2016\/8941327","volume":"2016","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., Tan, F., Xu, P. & Qu, S. Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson\u2019s Disease. Neural Plast. 2016, 8941327 (2016).","journal-title":"Neural Plast."},{"key":"2613_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41531-025-00902-7","volume":"11","author":"C Mu","year":"2025","unstructured":"Mu, C. et al. Lysophosphatidylcholine promoting \u03b1-Synuclein aggregation in Parkinson\u2019s disease: disrupting GCase glycosylation and lysosomal \u03b1-Synuclein degradation. NPJ Parkinsons Dis. 11, 47 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"2613_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cmet.2018.05.019","volume":"28","author":"G Lin","year":"2018","unstructured":"Lin, G. et al. Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to \u03b1-Synuclein Gain. Cell Metab. 28, 605\u2013618.e6 (2018).","journal-title":"Cell Metab."},{"key":"2613_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155899","volume":"7","author":"H Rehman","year":"2022","unstructured":"Rehman, H. et al. ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors. JCI Insight 7, e155899 (2022).","journal-title":"JCI Insight"},{"key":"2613_CR42","doi-asserted-by":"publisher","first-page":"15108","DOI":"10.1007\/s12035-025-05113-y","volume":"62","author":"R AlRuwaili","year":"2025","unstructured":"AlRuwaili, R. et al. Targeting of the PI3 K\/AKT\/GSK3\u03b2 Pathway in Parkinson\u2019s Disease: A Therapeutic Blueprint. Mol. Neurobiol. 62, 15108\u201315131 (2025).","journal-title":"Mol. Neurobiol."},{"key":"2613_CR43","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1007\/s00204-024-03829-9","volume":"98","author":"PK Keshri","year":"2024","unstructured":"Keshri, P. K. & Singh, S. P. Unraveling the AKT\/ERK cascade and its role in Parkinson disease. Arch. Toxicol. 98, 3169\u20133190 (2024).","journal-title":"Arch. Toxicol."},{"key":"2613_CR44","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.2147\/DDDT.S462333","volume":"18","author":"B Cai","year":"2024","unstructured":"Cai, B. et al. Integrating Network Pharmacology, Transcriptomics to Reveal Neuroprotective of Curcumin Activate PI3K \/ AKT Pathway in Parkinson\u2019s Disease. Drug Des. Devel Ther. 18, 2869\u20132881 (2024).","journal-title":"Drug Des. Devel Ther."},{"key":"2613_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14788-x","volume":"11","author":"Y Wei","year":"2020","unstructured":"Wei, Y. et al. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection. Nat. Commun. 11, 941 (2020).","journal-title":"Nat. Commun."},{"key":"2613_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/mds.28826","volume":"37","author":"S Charisis","year":"2022","unstructured":"Charisis, S. et al. Plasma Glutathione and Prodromal Parkinson\u2019s Disease Probability. Mov. Disord. 37, 200\u2013205 (2022).","journal-title":"Mov. Disord."},{"key":"2613_CR47","doi-asserted-by":"publisher","first-page":"156330","DOI":"10.1016\/j.metabol.2025.156330","volume":"170","author":"M Hole\u010dek","year":"2025","unstructured":"Hole\u010dek, M. Glycine as a conditionally essential amino acid and its relationship to l-serine. Metabolism 170, 156330 (2025).","journal-title":"Metabolism"},{"key":"2613_CR48","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neubiorev.2020.10.004","volume":"120","author":"G Bj\u00f8rklund","year":"2021","unstructured":"Bj\u00f8rklund, G. et al. The glutathione system in Parkinson\u2019s disease and its progression. Neurosci. Biobehav Rev. 120, 470\u2013478 (2021).","journal-title":"Neurosci. Biobehav Rev."},{"key":"2613_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67890-1","volume":"14","author":"Q Sun","year":"2024","unstructured":"Sun, Q., Li, Y.-J. & Ning, S.-B. Investigating the molecular mechanisms underlying the co-occurrence of Parkinson\u2019s disease and inflammatory bowel disease through the integration of multiple datasets. Sci. Rep. 14, 17028 (2024).","journal-title":"Sci. Rep."},{"key":"2613_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/toxins9020052","volume":"9","author":"T Gryp","year":"2017","unstructured":"Gryp, T., Vanholder, R., Vaneechoutte, M. & Glorieux, G. p-Cresyl Sulfate. Toxins (Basel). 9, 52 (2017).","journal-title":"Toxins (Basel)."},{"key":"2613_CR51","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3390\/microorganisms11051317","volume":"11","author":"F Blachier","year":"2023","unstructured":"Blachier, F. Amino Acid-Derived Bacterial Metabolites in the Colorectal Luminal Fluid: Effects on Microbial Communication, Metabolism, Physiology, and Growth. Microorganisms 11, 1317 (2023).","journal-title":"Microorganisms"},{"key":"2613_CR52","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1021\/acsptsci.5c00289","volume":"8","author":"L Bertarini","year":"2025","unstructured":"Bertarini, L. et al. Para-Cresol and the Brain: Emerging Role in Neurodevelopmental and Neurodegenerative Disorders and Therapeutic Perspectives. ACS Pharm. Transl. Sci. 8, 3432\u20133452 (2025).","journal-title":"ACS Pharm. Transl. Sci."},{"key":"2613_CR53","doi-asserted-by":"publisher","first-page":"2431651","DOI":"10.1080\/19490976.2024.2431651","volume":"16","author":"SN Shah","year":"2024","unstructured":"Shah, S. N. et al. Cerebrovascular damage caused by the gut microbe\/host co-metabolite p-cresol sulfate is prevented by blockade of the EGF receptor. Gut Microbes 16, 2431651 (2024).","journal-title":"Gut Microbes"},{"key":"2613_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01934-6","volume":"12","author":"T Wang","year":"2024","unstructured":"Wang, T. et al. Xylanase enhances gut microbiota-derived butyrate to exert immune-protective effects in a histone deacetylase-dependent manner. Microbiome 12, 212 (2024).","journal-title":"Microbiome"},{"key":"2613_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-025-02095-w","volume":"13","author":"JY Lee","year":"2025","unstructured":"Lee, J. Y. et al. Distinct gut microbiome characteristics and dynamics in patients with Parkinson\u2019s disease based on the presence of premotor rapid-eye movement sleep behavior disorders. Microbiome 13, 108 (2025).","journal-title":"Microbiome"},{"key":"2613_CR56","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3389\/fmicb.2018.02161","volume":"9","author":"SA Huws","year":"2018","unstructured":"Huws, S. A. et al. Addressing Global Ruminant Agricultural Challenges Through Understanding the Rumen Microbiome: Past, Present, and Future. Front Microbiol. 9, 2161 (2018).","journal-title":"Front Microbiol."},{"key":"2613_CR57","doi-asserted-by":"publisher","first-page":"e0050324","DOI":"10.1128\/iai.00503-24","volume":"93","author":"M Tingler Anna","year":"2025","unstructured":"Tingler Anna, M. & Engevik Melinda, A. Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?. Infect. Immun. 93, e0050324 (2025).","journal-title":"Infect. Immun."},{"key":"2613_CR58","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1073\/pnas.1006451107","volume":"108","author":"ME Johansson","year":"2011","unstructured":"Johansson, M. E., Larsson, J. M. & Hansson, G. C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. Usa. 108, 4659\u20134665 (2011).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"2613_CR59","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"2613_CR60","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1212\/WNL.0000000000002414","volume":"86","author":"JC Wong","year":"2016","unstructured":"Wong, J. C. et al. Risk factors for probable REM sleep behavior disorder: A community-based study. Neurology 86, 1306\u20131312 (2016).","journal-title":"Neurology"},{"key":"2613_CR61","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.sleep.2014.03.020","volume":"15","author":"SS Shen","year":"2014","unstructured":"Shen, S. S. et al. Validation study of REM sleep behavior disorder questionnaire-Hong Kong (RBDQ-HK) in east China. Sleep. Med. 15, 952\u2013958 (2014).","journal-title":"Sleep. Med."},{"key":"2613_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.sleep.2009.06.008","volume":"11","author":"SX Li","year":"2010","unstructured":"Li, S. X. et al. Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). Sleep. Med. 11, 43\u201348 (2010).","journal-title":"Sleep. Med."},{"key":"2613_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/jnnp-2024-333865","volume":"96","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Visuospatial dysfunction predicts dementia-first phenoconversion in isolated REM sleep behaviour disorder. J. Neurol. Neurosurg. Psychiatry 96, 76\u201384 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2613_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41531-021-00155-0","volume":"7","author":"T Shen","year":"2021","unstructured":"Shen, T. et al. The role of brain perivascular space burden in early-stage Parkinson\u2019s disease. NPJ Parkinsons Dis. 7, 12 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"2613_CR65","doi-asserted-by":"publisher","first-page":"101466","DOI":"10.1016\/j.smrv.2021.101466","volume":"57","author":"M Bergmann","year":"2021","unstructured":"Bergmann, M. et al. Sleep quality and daytime sleepiness in epilepsy: Systematic review and meta-analysis of 25 studies including 8196 individuals. Sleep. Med Rev. 57, 101466 (2021).","journal-title":"Sleep. Med Rev."},{"key":"2613_CR66","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-023-01552-y","volume":"8","author":"Y Shao","year":"2023","unstructured":"Shao, Y. et al. A metabolome atlas of mouse brain on the global metabolic signature dynamics following short-term fasting. Signal Transduct. Target Ther. 8, 334 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2613_CR67","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.1021\/acs.analchem.8b01482","volume":"90","author":"X Zhao","year":"2018","unstructured":"Zhao, X. et al. Comprehensive Strategy to Construct In-House Database for Accurate and Batch Identification of Small Molecular Metabolites. Anal. Chem. 90, 7635\u20137643 (2018).","journal-title":"Anal. Chem."},{"key":"2613_CR68","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","volume":"12","author":"H Tsugawa","year":"2015","unstructured":"Tsugawa, H. et al. MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis. Nat. Methods 12, 523\u2013526 (2015).","journal-title":"Nat. Methods"},{"key":"2613_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009148","volume":"17","author":"P Castellano-Escuder","year":"2021","unstructured":"Castellano-Escuder, P. et al. POMAShiny: A user-friendly web-based workflow for metabolomics and proteomics data analysis. PLoS Comput Biol. 17, e1009148 (2021).","journal-title":"PLoS Comput Biol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02613-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:02:45Z","timestamp":1774882965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02613-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02613-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}